Engineering light-controlled proteins

Jul 03, 2014
Engineering light-controlled proteins
Mark Gomelsky, a professor in the UW Department of Molecular Biology, is senior writer of a paper that appeared in the Early Edition of the Proceedings of the National Academy of Sciences. He has engineered proteins that can be activated by near-infrared light as a way to control biological activities in deep tissues of small mammals.Credit: UW Photo

(Phys.org) —A University of Wyoming professor has engineered proteins that can be activated by near-infrared light as a way to control biological activities in deep tissues of small mammals.

Currently, such proteins will be used as research tools to better understand the biology of diseases and the biology of organismal development, says Mark Gomelsky, a professor in the UW Department of Molecular Biology. With advances in cell engineering, he expects these proteins to aid in fighting cancer, heart disease and other illnesses.

"Near-infrared light penetrates through the tissues of animals and humans to the depth of several centimeters. We're designing proteins whose activities will respond to such light," Gomelsky says. "Mammalian cells that are genetically engineered to make such proteins can be controlled by light even in deep animal tissues. We want to design a tool set of light-activated proteins with different capabilities to enable researchers to control diverse biological processes.

"Light may seem a strange way to control cellular activities. However, if orthodox thinking is put aside, light is an ideal drug."

That is because light acts specifically and activates only its engineered target without interfering with mammalian physiology, making it nontoxic, Gomelsky says. Light also offers spatial and temporal precision that no chemical can achieve.

Gomelsky is a senior writer of a paper, titled "Engineering Adenylate Cyclases Regulated by Near-Infrared Window Light," that appeared in the June 30 Early Edition of the Proceedings of the National Academy of Sciences (PNAS). The journal is one of the world's most prestigious multidisciplinary scientific serials, with coverage spanning the biological, physical and social sciences. This is the second time Gomelsky's research has been published in PNAS.

"This study is a proof of principle that we can engineer near-infrared, light-activated proteins," he says.

Studying the Near-Infrared

Gomelsky's research team constructed a near-infrared, light-activated adenylate cyclases, an enzyme that regulates various processes in mammals—from sleep and memory to heart rhythms and tumor cell proliferation.

In previous research, Gomelsky characterized a blue-light activated adenylyl cyclase, which has since been used to study signaling processes in flies and roundworms. Because of the superior properties of the , the engineered near-infrared version can be used in mice and rats, animal models that are much more informative for human biology.

Blue light, like most other light in the visible spectrum, penetrates through mammalian tissue very poorly. This contrasts with red light and, especially, light at the border with near-infrared. To demonstrate the effectiveness of red light, Gomelsky pressed a laser pointer against his thumb. Red light made interior tissue easily visible. When he used a blue laser pointer, interior tissue was not visible.

To test how their engineered protein works in animals, Gomelsky collaborated with two University of Pennsylvania researchers who placed the proteins in the neurons that control body movements of roundworms. When researchers exposed the worms to red light, the animals increased their body-bending frequency, as was expected. When researchers turned the light off, the worms quickly returned to normal movements.

"This was not a fancy application," Gomelsky says. "But it was important to demonstrate that the research tool that we engineered, tested and optimized in bacteria, works in animals."

Potential future applications

When invited to speculate about potential future applications of the near-infrared proteins, Gomelsky gets excited.

"Medicine is undergoing a drastic change. It's moving from exclusively chemistry-based medicine, that uses small chemical as drugs, toward protein- and cell-based medicine," Gomelsky says. "In recent years, there has been tremendous progress in our ability to engineer cells to perform specific functions. For instance, to recognize and kill tumor cells, or to repair damaged organs."

Currently, one of the big problems with engineered cells is that they cannot be controlled once they are deployed in a patient, Gomelsky says. So, if some engineered cells misbehave, there is no easy way to correct that.

"We want to build, into these cells, a turn-off switch that can be remotely activated," he says. "By using this switch, it would be possible to bring the mischievous cell to order or to destroy them."

Caspase is the name of one of the proteins that Gomelsky's laboratory students are trying to make light-responsive. This protein can induce death. A built-in, light-sensitive caspase could allow physicians to kill mischievous engineered cells in the body of a patient if these cells were to wander into wrong tissues. Such proteins also could be made into an anti-cancer weapon.

"Chemotherapy, one of the most common ways to treat cancer, is like carpet bombing," Gomelsky says, offering an example. While chemotherapy kills many tumor cells, it does not kill all of them and the collateral damage is enormous. "From carpet bombing, we are moving to smart weapons like engineered cells that can recognize and kill . What these cells lack is the remote control to adjust their behavior after they have been deployed. We hope that near-infrared can be used for this purpose, much like it currently is used to turn on TV sets or to unlock car doors."

UW assistance

Most of the paper's other writers are from UW. These include the paper's lead writer, Min-Hyung Ryu, a recent UW doctoral student in molecular biology, who currently is a postdoctoral fellow in synthetic biology at Massachusetts Institute of Technology; In-Hye Kang, a former UW research assistant in molecular biology; Anna Lyuksyutova, a UW research professor in molecular biology; Jessica Siltberg-Liberies, a former UW bioinformatician who is now an assistant professor at Florida International University; and Tricia Jensen, a recent UW graduate admitted to the WWAMI medical education program.

Other contributors include David Raizen, an assistant professor of neurology; and Matthew Nelson, a post-doctoral fellow, both from the University of Pennsylvania.

The research initially was funded by a pilot grant from the Wyoming IDeA Networks for Biomedical Research Excellence (INBRE), and subsequently supported by a grant from National Institutes of Health. Gomelsky credits Wyoming's Experimental Program to Stimulate Competitive Research (EPSCoR) from the National Science Foundation and the Wyoming NASA Space Grant Consortium scholarships for supporting Jensen and other undergraduate researchers, Ryan Griesbach and Steve Schoeber, whose contributions are acknowledged in the paper.

A patent for the method of engineering near-infrared protein was filed with UW's Office of Research and Product Development, Gomelsky says.

"At this point, our tool has mostly scientific value, but not yet a commercial value," he says.

Explore further: Enlightening cancer cells

More information: Min-Hyung Ryu, In-Hye Kang, Mathew D. Nelson, Tricia M. Jensen, Anna I. Lyuksyutova, Jessica Siltberg-Liberles, David M. Raizen, and Mark Gomelsky. "Engineering adenylate cyclases regulated by near-infrared window light." PNAS 2014 ; published ahead of print June 30, 2014, DOI: 10.1073/pnas.1324301111

add to favorites email to friend print save as pdf

Related Stories

Enlightening cancer cells

Jul 01, 2014

Joint EMBO Journal paper by IST Austria and Vienna Medical University groups on engineered cell surface receptors activated by light. Small algal protein domains serve as synthetic light sensors in human ...

Keeping harmful bacteria from progressing

Jul 08, 2009

(PhysOrg.com) -- Researchers from the University of Wyoming and an institute in Germany have completed a project that, for the first time, has identified how sunlight changes activity of a particular class of proteins called ...

Recommended for you

Researchers discover new strategy germs use to invade cells

Aug 20, 2014

The hospital germ Pseudomonas aeruginosa wraps itself into the membrane of human cells: A team led by Dr. Thorsten Eierhoff and Junior Professor Dr. Winfried Römer from the Institute of Biology II, members of the Cluster ...

Progress in the fight against harmful fungi

Aug 20, 2014

A group of researchers at the Max F. Perutz Laboratories has created one of the three world's largest gene libraries for the Candida glabrata yeast, which is harmful to humans. Molecular analysis of the Candida ...

How steroid hormones enable plants to grow

Aug 19, 2014

Plants can adapt extremely quickly to changes in their environment. Hormones, chemical messengers that are activated in direct response to light and temperature stimuli help them achieve this. Plant steroid ...

Surviving the attack of killer microbes

Aug 19, 2014

The ability to find food and avoid predation dictates whether most organisms live to spread their genes to the next generation or die trying. But for some species of microbe, a unique virus changes the rules ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

Returners
1 / 5 (2) Jul 03, 2014
With advances in cell engineering, he expects these proteins to aid in fighting cancer, heart disease and other illnesses.


nice.

"We want to build, into these cells, a turn-off switch that can be remotely activated," he says. "By using this switch, it would be possible to bring the mischievous cell to order or to destroy them."


I'm assuming he's talking about the "cancer vaccines" which take a patient's own white blood cells and re-engineer them to fight cancer. I think another common one is the beta cells (i think) used in the Pancrease(?).

One problem I can foresee is that a "misbehaving" cell might also begin over-producing the "kill switch" protein, causing additional damage when you attempt to activate it. Suggestion in this case would be short exposures of the light, in non-vital areas if possible, when attempting to rein in such cells, that way you guarantee you don't cause un-wanted cell damage to vital systems.
Returners
2.3 / 5 (3) Jul 03, 2014
Wouldn't it be nice to design antibiotics which are only activate by certain wavelengths of light? This way you could treat internal infections more efficiently by ensuring that the new "drug" is only activated in the region where the infection is most concentrated.

Let's say the patient has a kidney or bladder infection. It would be useful to attack the offending pathogen in the organ it best inhabits, and worry less about stray amounts of it elsewhere, since presumably other systems of the body are less prone to progressive infection. Traditional antibiotics and anti-virals can't really be targeted that way.

A way to do this would be to design a molecule who's receptor is covered by a photo-reactive molecule, which breaks off under certain wavelengths of light. Alternatively, you could have a molecule which reacts to form an antibiotic by combining with substances in the blood or other body fluids.
TheGhostofOtto1923
1 / 5 (1) Jul 03, 2014
One problem I can foresee is that a "misbehaving" cell might also begin over-producing the "kill switch" protein, causing additional damage when you attempt to activate it. Suggestion in this case would be short exposures of the light, in non-vital areas if possible, when attempting to rein in
Suggestion please don't presume to tell molecular biologists (or cosmologists or physicists or infectious disease researchers etc) how to do their work, it only makes you look like a delusional megalomaniac.